Steven Sckolnik, MD
Radiation Oncology · Phoenix, AZNPI 1881956894
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (37.1%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by GT Medical Technologies, Inc at 55.8% of the total. Reporting peaked in 2024 at $5,100 and has fallen 80.8% since, to $977 in 2025.
Across 70 payments — averaging $139.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GT Medical Technologies, Inc$5K
- AstraZeneca$2K
- Elekta, Inc.$245
- Icotec Medical Inc.$214
- Intuitive Surgical$196
- Steris Corporation$186
- plus $1K from 19 others
What the payments were for
- Consulting fees$3,10032%
- Travel & lodging$3,63537%
- Food & beverage$3,02731%
- Entertainment$340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GT Medical Technologies, Inc | 16 | $5,463 |
| AstraZeneca | 4 | $2,100 |
| Elekta, Inc. | 2 | $245 |
| Icotec Medical Inc. | 2 | $214 |
| Intuitive Surgical | 2 | $196 |
| Steris Corporation | 1 | $186 |
| Progenics Pharmaceuticals, Inc. | 6 | $157 |
| Advanced Accelerator Applications | 2 | $148 |
| Varian Medical Systems, Inc. | 2 | $144 |
| Johnson & Johnson(2 entities) | 2 | $132 |
| Pfizer | 6 | $120 |
| Sobi, Inc | 3 | $75 |
| Tactile Systems Technology Inc | 3 | $75 |
| Daiichi Sankyo Inc. | 3 | $74 |
| Siemens Medical Solutions USA, Inc. | 1 | $67 |
| Teleflex LLC | 2 | $66 |
| AbbVie | 2 | $50 |
| Novartis | 2 | $46 |
| Incyte Corporation | 2 | $44 |
| Merck | 2 | $44 |
| Argentum Medical | 1 | $34 |
| GE HealthCare | 1 | $33 |
| Blue Earth Diagnostics | 1 | $32 |
| Novocure Inc. | 1 | $31 |
| Boston Scientific | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,795 in reported general payments places this provider in the 85th percentile of 138 radiation oncology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 48 | $777 |
| Mometasone Furoate | 30 | $607 |
| Dexamethasone | 21 | $440 |
| Morphine Sulfate ErMorphine Sulfate | 11 | $242 |
| Bicalutamide | 13 | $193 |
| Oxycodone Hcl | 14 | $147 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Phoenix
- John KreslPhoenix$248K
- Subhakar MutyalaPhoenix$12K
- Lauren StegmanPhoenix$10K
- Igor BaraniPhoenix$10K
- Joshua NiskaPhoenix$8K
- Gerald LucasPhoenix$7K
- Abhilash NambiarPhoenix$7K
- Justin FamosoPhoenix$5K
- Winlove SuasinPhoenix$3K
- Devin SloanPhoenix$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.